Ensartinib
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLC (NCT07235306) | Shanghai Pulmonary Hospital, Shanghai, China | 2025-12-01 |
| A Multicenter Real-world Clinical Study on the Efficacy and Safety of Ensartinib As Neoadjuvant Treatment for Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer (NSCLC) Patients. (NCT06736561) | Harbin Medical University | 2025-01-01 |
| A Real World Study of Ensartinib in Advanced ALK-positive NSCLC (NCT05498064) | Peking Union Medical College Hospital | 2022-05-13 |
Track Ensartinib automatically
Every clearance here is in the API, with alerts when new ones post.